The Biotechnology R&D intensity in Canada's business sector displayed fluctuating trends from 2016 to 2023, reflecting a dynamic industry landscape. In 2023, the R&D intensity stood at 5.15 units of BERD. Key variations include a notable increase of 30.04% in 2021 contrasted by a minor decline of 4.32% in 2022. The overall compound annual growth rate (CAGR) from 2018 to 2023 was 2.82%. Looking at forecast data, from 2024 to 2028, a steady growth with a CAGR of 1.33% is projected, indicating a stable, albeit modest, rise in R&D investment intensity over the upcoming years.
Future trends to watch for:
- Enhanced government support and incentives for biotech innovation.
- Increased collaboration between academia and the private sector.
- Rising demand for biotechnology solutions in healthcare and environmental sustainability.
- Potential impact of global economic shifts and trade policies on R&D funding.
